JPRN-jRCT2031220322进行中（未招募）1 期
An Open-label, Randomized, Single-dose, Crossover Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-0616 in Healthy Japanese, Chinese, and Caucasian Participants
Tanaka Yoshiyuki0 个研究点目标入组 14 人开始时间: 2022年9月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 25age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •Healthy Japanese, Chinese or Caucasian male participants and female participants of nonchildbearing potential between the ages of 25 and 65 years
排除标准
- •Has a history of clinically significant abnormalities or diseases
研究者
相似试验
已完成
不适用
A clinical trial to evaluate and compare the blood levels of two aliskiren modified release formulations with aliskiren market tablet in healthy adult subjectsCTRI/2011/12/002235ovartis Healthcare Private Limited42
已完成
不适用
Cinical trial of the safety and pharmacokinetic characteristics between TuNEX 25 mg and Enbrel 25 mg subcutaneous injections in healthy male volunteersDiseases of the musculo-skeletal system and connective tissueKCT0000118Bio Trion24
尚未招募
不适用
Bioequivalent study for a generic product of fluconazole capsule 50 mgKCT0003344Pfizer Pharmacueticals Korea28
已完成
不适用
A Single-Dose, Open-label, Randomized, Crossover, Multipart, Multicenter Study to Assess the Relative Oral Bioavailability of a JNJ-77242113 Immediate-release Tablet Formulation with Respect to a Solution Formulation and Food Effect of an Immediate-release Tablet Formulation, and to Assess the Relative Oral Bioavailability, Dose Proportionality, and Food Effect of JNJ-77242113 Delayed-release Tablet Formulations in Healthy ParticipantsNL-OMON52057Janssen-Cilag International NV82
已完成
不适用
A randomized, open-label, single-dose, crossover study to compare the safety, tolerability and pharmacokinetics of ginsenosides after oral administrations of fermented Red ginseng concentrate and Red ginseng concentrate in healthy volunteersKCT0006791Kyung Hee University Hospital16